Although sinus infections are the fifth leading reason for antibiotic prescriptions, 90-98 percent of cases are caused by viruses, which are not affected by antibiotics. Improper antibiotic administration could foster the development of drug-resistant superbugs.
The guidelines — the first developed by IDSA on this topic — provide specific characteristics of the illness to help physicians distinguish between viral and bacterial sinus infections. The guidelines also provide treatment recommendations for physicians in case a sinus infection is bacterial.
“There is no simple test that will easily and quickly determine whether a sinus infection is viral or bacterial, so many physicians prescribe antibiotics ‘just in case,'” said Anthony W. Chow, MD, chair of the guidelines panel and professor emeritus of infectious diseases at the University of British Columbia, Vancouver. “However, if the infection turns out to be viral — as most are — the antibiotics won’t help and in fact can cause harm by increasing antibiotic resistance, exposing patients to drug side effects unnecessarily and adding cost.”
Related Articles on Antibiotics:
On the Quest for Quality: How McLeod Health Reduced Mortality by 28%
Infectious Disease Societies Call for Increased Focus on Antimicrobial Stewardship
IDSA Proposes New Pathway for Antibiotic Approval
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.